CN106478522A — 一种马西替坦杂质标准品的制备方法
Assigned to HEFEI JIUNUO MEDICAL TECHNOLOGY Co Ltd · Expires 2017-03-08 · 9y expired
What this patent protects
本发明公开了一种马西替坦杂质标准品的制备方法,是以5‑(4‑溴苯基)‑4,6‑二氯嘧啶为原料,分别与N‑丙基磺酰胺、乙二醇缩合制得1,2‑二[[N‑[5‑(4‑溴苯基)]‑N'‑丙基磺酰胺‑6‑氧代]嘧啶基]乙基二醚粗品,粗品经精制而得纯品,纯品采用常规的分析手段标定含量。本发明提供的杂质制备方法工艺简捷、制备周期短,经标定的产品含量大于99.0%。本发明提供的马西替坦杂质可作为杂质标准品,应用于马西替坦原料及其制剂杂质的定性、定量研究和检测。
USPTO Abstract
本发明公开了一种马西替坦杂质标准品的制备方法,是以5‑(4‑溴苯基)‑4,6‑二氯嘧啶为原料,分别与N‑丙基磺酰胺、乙二醇缩合制得1,2‑二[[N‑[5‑(4‑溴苯基)]‑N'‑丙基磺酰胺‑6‑氧代]嘧啶基]乙基二醚粗品,粗品经精制而得纯品,纯品采用常规的分析手段标定含量。本发明提供的杂质制备方法工艺简捷、制备周期短,经标定的产品含量大于99.0%。本发明提供的马西替坦杂质可作为杂质标准品,应用于马西替坦原料及其制剂杂质的定性、定量研究和检测。
Drugs covered by this patent
- Opsumit (MACITENTAN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.